BlackRock, Inc.

Holdings History for Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX)

Symbol: PTGX on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001
Latest Disclosed Ownership: 8.58M shares
Security Ownership: 13.8%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in Protagonist Therapeutics, Inc Common Stock, par value $0.00001 (PTGX)

2025-10-17 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.58M shares of Protagonist Therapeutics, Inc Common Stock, par value $0.00001 (PTGX). This represents 13.8% percent ownership of the company. In their previous filing dated 2025-04-29, BlackRock, Inc. had reported owning 9.08M shares, indicating a decrease of -5.6% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BlackRock, Inc.	13.8%	-6.67%	$570M	8.58M	-509,013	-5.6%	$66.43	13G/A	9/30/2025	17 Oct 2025 18:24:03
BlackRock, Inc.	14.8%	-10.6%	$387M	9.08M	-799,935	-8.09%	$42.57	13G/A	3/31/2025	29 Apr 2025 14:53:22
BlackRock, Inc.	16.6%		$421M	9.88M			$42.57	13G/A	12/31/2024	5 Feb 2025 13:23:37

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	0%	$625M	9.4M	-226,109	-2.35%	$66.43	Q3 2025
6/30/2025	0.01%	0%	$532M	9.63M	-106,426	-1.09%	$55.27	Q2 2025
3/31/2025	0.01%	0%	$471M	9.74M	-147,850		$48.36	Q1 2025
12/31/2024	0.01%	0%	$382M	9.88M	-339,678	-3.32%	$38.60	Q4 2024
9/30/2024	0.01%		$460M	10.2M			$45.00	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.